Immunotherapy

Groundbreaking Trial Shows How Immunotherapy "Changes the Outlook" of Some Cancers

A new drug that has cured patients of rectal cancer is bringing global attention to the benefits and potential of immunotherapy. National Cancer Institute-designated cancer centers like the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) are leading the way in studying the immune regulation of malignant disease to develop novel diagnostic, preventive and treatment regimens.